PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Noetix Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

U.S Pharmacopeia Selects Jaros to Provide a Single Source of Business Information - Jaros Analytics integrates and delivers information from across the USP enterprise to provide a single source of the truth to decision-makers throughout the organization - USP.org / JarosTech.com
U.S Pharmacopeia Selects Jaros to Provide a Single Source of Business Information

 

NewswireToday - /newswire/ - Granite City, IL, United States, 2006/11/28 - Jaros Analytics integrates and delivers information from across the USP enterprise to provide a single source of the truth to decision-makers throughout the organization - USP.org / JarosTech.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Jaros Technologies, a leading provider of Business Performance Management solutions, today announced that U.S. Pharmacopeia (USP), a non-profit organization that establishes standards for pharmaceuticals, dietary supplements and other health care products, has implemented solutions from Jaros Technologies as their standard for data integration, analysis and reporting in support of business decisions.

"We wanted all of our scientific and financial information available, at our fingertips and in a single repository so we could perform analysis and gain knowledge across all spectrums of USP’s functional areas," said Steve Mendelsohn, Vice President of Finance at USP. "We needed visibility and transparency across departments without having to access individual databases and spreadsheets and then manually make the connections between data points and key performance indicators. Jaros represents an end-to-end solution that provides USP with new insight and the tools necessary to enhance our ability to view the performance of our business."

With Jaros providing the core technology, USP has developed a "Mission Management System" (MMS) that is the standard resource for all business reporting and analysis. The MMS includes information from most USP departments including Standards Development, Standards Operations, Marketing & Sales, Information Technology, Corporate Planning, and Finance & Administration. Jaros provides the only technology with packaged solutions specifically designed to integrate and present detailed information from across departments, quickly delivering both operational reporting as well as sophisticated analytics.

"While other vendors focus on front-end reporting applications, Jaros goes a step farther," stated Paul Saxon, Director of Software & Systems Development at USP. "Jaros delivers best-of-breed reporting solutions, but more importantly, Jaros brings the data together, creating a cohesive information foundation for its Business Intelligence solutions."

Jaros offers a packaged information framework that delivers reporting solutions based on a loosely configured, quickly customized data warehouse and operational data store. With the most complete package of business requirement based reporting and analytic solutions, Jaros enables USP to leverage the data in their Oracle Applications and disparate systems to gain true insight into business performance and processes.

"With a higher level of visibility into our performance and processes, we are positioned to measure and analyze the state of the company today, accurately forecast upcoming events, and proactively shape the company we envision USP will be in years to come," adds Saxon.

USP is currently focused on the direction of the company and creating more efficiencies through better use of technology. The Mission Management System plays a key role in allowing the organization to grow and remain competitive. USP’s business users began using the Mission Management System based on Jaros Solutions in July of 2006.

About United States Pharmacopeia (USP)
The USP (usp.org) is a nonprofit, nongovernmental, standard-setting organization that advances public health by ensuring the quality and consistency of medicines, promoting the safe and proper use of medications, and verifying ingredients in dietary supplements. These standards, which are recognized worldwide, are developed by a unique process of public involvement through the contributions of volunteers representing pharmacy, medicine, and other health care professions, as well as science, academia, government, the pharmaceutical industry, and consumer organizations.

About Jaros
Jaros (jarostech.com) is a leading provider of packaged Business Performance and Intelligence Solutions for the manufacturing industry. Jaros offers a packaged information framework comprised of a loosely configured, quickly customized data warehouse and operational data store. Jaros Solutions are functionally specific packaged reporting and analytic solutions based on this information framework. Jaros delivers a complete package of business requirement based reporting and analytic solutions, enabling organizations to Focus On The Business not the technology.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Noetix Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


U.S Pharmacopeia Selects Jaros to Provide a Single Source of Business Information

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: JarosTech.com 
618-452-8080 pr[.]jarostech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Noetix Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Noetix Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)